Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy
Clinical trial NCT07453095 · RECRUITING
Trial details
- NCT number
- NCT07453095
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2028-07-15
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.